Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

ViroPharma Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

24 Jan 2014 Reuters Investment Profile 12 $20.00

ViroPharma Inc

25 Jan 2014 S&P Capital IQ Factual Report 11 $127.00

Wright Investors Service Comprehensive Report for ViroPharma Incorporated

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

22 Jan 2014 Wright Reports 42 $75.00

NO FOMC Tapering this year

Tapering expectations (FOMC) for September are overblown. Our quant analysis suggests there will be no tapering in September...

22 Jan 2014 Stock Traders Daily 2 $23.00

The Investment Rate - a measure of investment demand.

The Investment Rate measures the demand for investments, including Real Estate, Stocks, and Private Business. The IR is a nor...

21 Jan 2014 Stock Traders Daily 43 $495.00

TheStreet.com Ratings Stock Report For: VIROPHARMA INC (VPHM)

19 Jan 2014 TheStreet.com Ratings 5 $10.00

Validea Guru Analysis Report for VPHM. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.

Validea's Guru Stock Report uses an interpretation of the published stock-picking strategies developed by 10 investing legend...

17 Jan 2014 Validea 0 $12.00

Value Graph: VIROPHARMA -- VPHM

17 Jan 2014 Ford Investor Services, Inc. 1 $12.00

VPHM - ViroPharma Inc - Downgraded to a Sell - Company Analysis and ASR Ranking Report

www.AlphaStreetResearch.com - Full Coverage of 3,000 U.S. equities. Reports include Financials, Ratios, Competitor Comparison...

16 Jan 2014 Alpha Street Research 9 $24.00

TheStreet.com Ratings Stock Report For: VIROPHARMA INC (VPHM)

12 Jan 2014 TheStreet.com Ratings 5 $10.00